Ke Si Wang

642 total citations
15 papers, 556 citations indexed

About

Ke Si Wang is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Ke Si Wang has authored 15 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 2 papers in Pharmacology. Recurrent topics in Ke Si Wang's work include Cancer, Hypoxia, and Metabolism (6 papers), NF-κB Signaling Pathways (5 papers) and Natural product bioactivities and synthesis (5 papers). Ke Si Wang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), NF-κB Signaling Pathways (5 papers) and Natural product bioactivities and synthesis (5 papers). Ke Si Wang collaborates with scholars based in China and United States. Ke Si Wang's co-authors include Chunliu Mi, Juan Ma, Xuezheng Li, Lian Xun Piao, Guang Xu, Xuejun Jin, Jung Joon Lee, Xuejun Jin, Zhe Wang and Ming Yue Li and has published in prestigious journals such as Journal of Ethnopharmacology, Oncotarget and Phytotherapy Research.

In The Last Decade

Ke Si Wang

15 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ke Si Wang China	13	333	115	94	73	71	15	556
Jeong‐Mi Kim South Korea	15	309 0.9×	94 0.8×	88 0.9×	46 0.6×	54 0.8×	45	668
Shengnan Wang China	13	313 0.9×	93 0.8×	116 1.2×	48 0.7×	40 0.6×	35	663
Hyo Jeong Yun South Korea	11	346 1.0×	88 0.8×	80 0.9×	40 0.5×	75 1.1×	15	677
Jixia Li China	15	347 1.0×	103 0.9×	51 0.5×	57 0.8×	98 1.4×	43	673
Amara Maryam China	13	388 1.2×	156 1.4×	55 0.6×	49 0.7×	90 1.3×	18	675
Yi‐Ting Hsi Taiwan	13	283 0.8×	118 1.0×	70 0.7×	116 1.6×	50 0.7×	15	480
Jae Hoon Kim South Korea	18	411 1.2×	94 0.8×	85 0.9×	44 0.6×	116 1.6×	34	778
Chun-Shu Yu Taiwan	14	362 1.1×	76 0.7×	51 0.5×	39 0.5×	70 1.0×	17	559
Young‐Choon Lee South Korea	7	251 0.8×	91 0.8×	80 0.9×	39 0.5×	46 0.6×	10	566
Jialin Sun China	14	366 1.1×	130 1.1×	73 0.8×	75 1.0×	87 1.2×	46	631

Countries citing papers authored by Ke Si Wang

Since Specialization

Citations

This map shows the geographic impact of Ke Si Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Si Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Si Wang more than expected).

Fields of papers citing papers by Ke Si Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Si Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Si Wang. The network helps show where Ke Si Wang may publish in the future.

Co-authorship network of co-authors of Ke Si Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Si Wang. A scholar is included among the top collaborators of Ke Si Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Si Wang. Ke Si Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Han, Li, Chunliu Mi, Ke Si Wang, et al.. (2021). Excisanin A suppresses proliferation by inhibiting hypoxiainducible factor-1α expression in human hepatocellular carcinoma cells. Tropical Journal of Pharmaceutical Research. 19(12). 2483–2489. 1 indexed citations

Zhang, Zhi Hong, Chunliu Mi, Ke Si Wang, et al.. (2017). Chelidonine inhibits TNF‐α‐induced inflammation by suppressing the NF‐κB pathways in HCT116 cells. Phytotherapy Research. 32(1). 65–75. 50 indexed citations

Mi, Chunliu, Juan Ma, Ke Si Wang, et al.. (2017). Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways. Journal of Ethnopharmacology. 203. 27–38. 99 indexed citations

Wang, Ke Si, Zhe Wang, Juan Ma, et al.. (2017). Imperatorin efficiently blocks TNF-α-mediated activation of ROS/PI3K/Akt/NF-κB pathway. Oncology Reports. 37(6). 3397–3404. 46 indexed citations

Mi, Chunliu, Juan Ma, Ke Si Wang, et al.. (2017). Amorfrutin A inhibits TNF-α induced JAK/STAT signaling, cell survival and proliferation of human cancer cells. Immunopharmacology and Immunotoxicology. 39(6). 338–347. 19 indexed citations

Li, Ming Yue, Chunliu Mi, Ke Si Wang, et al.. (2017). Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling. Chemico-Biological Interactions. 274. 58–67. 27 indexed citations

Li, Junbo, Juan Ma, Ke Si Wang, et al.. (2016). Baicalein inhibits TNF-α-induced NF-κB activation and expression of NF-κB-regulated target gene products. Oncology Reports. 36(5). 2771–2776. 47 indexed citations

Wang, Ke Si, Juan Ma, Chunliu Mi, et al.. (2016). Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity. Oncology Reports. 35(4). 2045–2052. 6 indexed citations

Ma, Juan, Ke Si Wang, Chunliu Mi, et al.. (2016). Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression. Molecular and Cellular Biochemistry. 422(1-2). 11–20. 43 indexed citations

10.

Ma, Juan, Jing Li, Ke Si Wang, et al.. (2016). Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways. International Immunopharmacology. 39. 1–9. 22 indexed citations

11.

Ma, Juan, Chunliu Mi, Ke Si Wang, Jung Joon Lee, & Xuejun Jin. (2016). Zinc finger protein 91 (ZFP91) activates HIF-1α via NF-κB/p65 to promote proliferation and tumorigenesis of colon cancer. Oncotarget. 7(24). 36551–36562. 44 indexed citations

12.

Wang, Ke Si, Junbo Li, Zhe Wang, et al.. (2016). Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways. Immunopharmacology and Immunotoxicology. 39(1). 28–36. 89 indexed citations

13.

Wang, Fei, Juan Ma, Ke Si Wang, et al.. (2015). Blockade of TNF-α-induced NF-κB signaling pathway and anti-cancer therapeutic response of dihydrotanshinone I. International Immunopharmacology. 28(1). 764–772. 38 indexed citations

14.

Ma, Juan, Chunliu Mi, Ke Si Wang, Jung Joon Lee, & Xuejun Jin. (2015). 4′,6-Dihydroxy-4-methoxyisoaurone inhibits TNF-α-induced NF-κB activation and expressions of NF-κB-regulated target gene products. Journal of Pharmacological Sciences. 130(2). 43–50. 13 indexed citations

15.

Li, Jing, Chunliu Mi, Juan Ma, et al.. (2015). Dihydrotanshinone I inhibits the translational expression of hypoxia-inducible factor-1α. Chemico-Biological Interactions. 240. 48–58. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact